First Patient Successfully Treated in Pain Prevention Study Prior and Post-Surgical Debridement of Venous Leg Ulcers
2/19/19: Professor Keith Harding, Principal Investigator, Welsh Wound Innovation Centre, commented: “We are pleased to initiate this important study looking at mitigating pain for patients with venous leg ulcers. The first patient was successfully treated, allowing the wound to be fully debrided without any reported sensation or pain. Pain associated with venous leg ulcers is a significant unmet need and I am excited by the potential of Medi-Solfen® in providing a convenient, safe and effective method of pain mitigation in such wounds. I look forward to delivering the full data following completion of the clinical trial.”
The MHRA Approves Phase IIa Clinical Trial Application for Tri-Solfen for Venous Leg Ulcers: Product to be Branded as Medi-Solfen
12/17/18: the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved its application for a Phase IIa clinical trial of Tri-Solfen® (for human use the product will be branded as Medi-Solfen®) for the treatment of pain during the surgical debridement of venous leg ulcers.